The global whole exome sequencing (WES) market is experiencing significant growth due to the increasing demand for precision medicine and advancements in genetic research. Key drivers fueling this expansion include the rising prevalence of genetic disorders, continuous technological innovations, and decreasing sequencing costs. However, challenges such as the high cost of sequencing infrastructure and complexities in data interpretation hinder market growth. The market is segmented by product (kits and services), technology (sequencing by synthesis, ion semiconductor), and application (diagnostics and research).
